Global Phage Display-based Antibody Discovery Platform Market Growth (Status and Outlook) 2025-2031

The global Phage Display-based Antibody Discovery Platform market size is predicted to grow from US$ 925 million in 2025 to US$ 1322 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.

Phage display is a technique that allows the selection of antibodies, or antibody fragments, with a specific binding affinity for a target antigen. Bacteriophages (viruses that infect bacteria) are engineered to display a library of antibody fragments on their surface then mixed with an immobilized target antigen. The phages that bind to the antigen are isolated and amplified. The process is repeated multiple times to isolate the phage that displays the highest binding affinity to the target antigen. Once the phage with the desired antibody fragment is identified, the DNA sequence encoding the fragment can be extracted and used to produce large quantities. The antibody fragments are derived from a library of light and heavy chains with minor or major alterations that are hypothesized to impact binding efficiency and/or specificity.Phage display is a versatile and powerful method for generating antibodies with high specificity, affinity and functionality.

United States market for Phage Display-based Antibody Discovery Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Phage Display-based Antibody Discovery Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Phage Display-based Antibody Discovery Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Phage Display-based Antibody Discovery Platform players cover Creative Biolabs, DH Life Sciences, LLC, Bio-Rad Laboratories, Inc, ProteoGenix, Charles River Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Phage Display-based Antibody Discovery Platform Industry Forecast” looks at past sales and reviews total world Phage Display-based Antibody Discovery Platform sales in 2024, providing a comprehensive analysis by region and market sector of projected Phage Display-based Antibody Discovery Platform sales for 2025 through 2031. With Phage Display-based Antibody Discovery Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phage Display-based Antibody Discovery Platform industry.

This Insight Report provides a comprehensive analysis of the global Phage Display-based Antibody Discovery Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Phage Display-based Antibody Discovery Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phage Display-based Antibody Discovery Platform market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phage Display-based Antibody Discovery Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phage Display-based Antibody Discovery Platform.

This report presents a comprehensive overview, market shares, and growth opportunities of Phage Display-based Antibody Discovery Platform market by product type, application, key players and key regions and countries.

Segmentation by Type:
T4 Phage
T7 Phage
λ Phage
Filamentous Phage

Segmentation by Application:
Basic Research
Clinical Diagnosis
Biologics Development

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Biolabs
DH Life Sciences, LLC
Bio-Rad Laboratories, Inc
ProteoGenix
Charles River Laboratories
Sino Biological, Inc.
Adagene
ImmunoPrecise Antibodies Ltd.
Specifica Inc.
Pharmaron

Please note: The report will take approximately 2 business days to prepare and deliver.